Optimizing Precision Medicine for Patients With Lung and Thyroid Cancer: Expert Office Hours and Guidance for the Multidisciplinary Team

Learn how medical oncology and pathology experts are identifying and treating patients with lung or thyroid cancers harboring a RET alteration or NTRK fusion with these downloadable slides and archived webcast from a live workshop.

Share

Program Content

Activities

RET and NTRK in Lung and Thyroid Cancer
Optimizing Precision Medicine for Patients With Lung and Thyroid Cancer: Guidance for the Multidisciplinary Team
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 16, 2023

View Activity

Activities

Lung and Thyroid Cancer Multidisciplinary Approach
Optimizing Precision Medicine for Patients With Lung and Thyroid Cancer: Guidance for the Multidisciplinary Team
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 14, 2023

Expires: December 13, 2024

View Activity

Faculty

cover img faculity

Vivek Subbiah, MD

Chief, Early-Phase Drug Development
Sarah Cannon Research Institute
Nashville, Tennessee

cover img faculity

Vamsidhar Velcheti, MD

Professor of Medicine
NYU Grossman School of Medicine
Medical Director
Thoracic Oncology Program
Laura and Isaac Perlmutter Cancer Center
An NCI-designated Comprehensive Cancer Center
New York, New York 

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Lilly.

Lilly